HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Viral Structural Proteins (VP(1))

Viral proteins that are components of the mature assembled VIRUS PARTICLES. They may include nucleocapsid core proteins (gag proteins), enzymes packaged within the virus particle (pol proteins), and membrane components (env proteins). These do not include the proteins encoded in the VIRAL GENOME that are produced in infected cells but which are not packaged in the mature virus particle,i.e. the so called non-structural proteins (VIRAL NONSTRUCTURAL PROTEINS).
Also Known As:
VP(1); VP(2); VP(3); VP(6); VP(7); Polypeptide VP1, Structural; Viral Structural Proteins VP; Virus Structural Proteins; Proteins, Viral Structural; Proteins, Virus Structural; Structural Polypeptide VP1; Structural Proteins, Viral; Structural Proteins, Virus; VP1, Structural Polypeptide
Networked: 171 relevant articles (1 outcomes, 9 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kariwa, Hiroaki: 2 articles (01/2018 - 06/2005)
2. Zhang, Jie: 2 articles (06/2017 - 01/2015)
3. Azad, T Mokhtari: 2 articles (06/2009 - 08/2007)
4. Gouya, Mohammad M: 2 articles (06/2009 - 08/2007)
5. Mahmudi, M: 2 articles (06/2009 - 08/2007)
6. Musavi, T: 2 articles (06/2009 - 08/2007)
7. Nategh, R: 2 articles (06/2009 - 08/2007)
8. Rad, K Samimi: 2 articles (06/2009 - 08/2007)
9. Rahimi, Pooneh: 2 articles (06/2009 - 08/2007)
10. Tabatabaie, H: 2 articles (06/2009 - 08/2007)

Related Diseases

1. Neuroblastoma
2. Infections
3. Neoplasms (Cancer)
08/01/1992 - "They included: (1)Vp (+), (2)IM (+), (3)more than 5 cm in diameter of the main tumor, and (4)gross type except single nodular tumor. "
01/01/1983 - "II. Relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins."
06/01/1981 - "The specificity of serum protection is linked to the oncornavirus associated with the AD755a tumor and the serum immunoprecipitates only virus structural proteins from the tumor cell surface. "
02/27/2023 - "The probability of malignancy increased 3.86-fold (95% CI: 2.61-5.11) in lesions of diameter ≥20 mm compared to lesions <20 mm, 2.58-fold (95% CI: 1.48-3.68) in lesions not determined with central hilar structure (CHS) compared to those determined with CHS, 6.85-fold (95% CI: 4.67-9.03) in lymph nodes observed with necrosis compared to those without necrosis, and 1.51-fold (95% CI: 0.41-2.61) in lymph nodes with a vascular pattern (VP) score of 2-3 compared to those with a VP score of 0-1. Visualization of coagulation necrosis with EBUS-B mode and the determination of VP 2-3 in power Doppler mode were seen to be the most important criteria of malignancy."
01/07/2015 - "Portal vein invasion (vp) 1 was defined as an invasion or tumor thrombus distal to the second branch of the portal vein, vp2 as an invasion or tumor thrombus in the second branch of the portal vein, vp3 as an invasion or tumor thrombus in the first branch of the portal vein, and vp4 as an invasion or tumor thrombus in the portal trunk or extending to a branch on the contralateral side. "
4. Virus Diseases (Viral Diseases)
5. Vesicular Stomatitis

Related Drugs and Biologics

1. Antibodies
2. Hemagglutinins (Hemagglutinin)
3. Proteins (Proteins, Gene)
4. Peptides (Polypeptides)
5. Etoposide (VP 16)
6. Neutralizing Antibodies
7. trioctyl phosphine oxide (TOPO)
8. Antigens
9. Viral Structural Proteins (VP(1))
10. DNA (Deoxyribonucleic Acid)

Related Therapies and Procedures

1. Thrombectomy
2. Therapeutics
3. Sutures (Suture)
4. Surgical Instruments (Clip)
5. Immunotherapy